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Objectives: to examine the level of agreement among vascular surgeons and interventional radiologists regarding their
preference for the surgical or endovascular management of severe limb ischaemia.
Design: Delphi consensus study using 596 different hypothetical patient scenarios.
Participants: Delphi consensus group for the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
Methods: twenty consultant vascular surgeons and 17 interventional radiologists completed both rounds of the study. The
scenarios detailed the anatomical extent of disease, whether the patients had rest pain only or had tissue loss, and whether or
not a suitable vein for bypass was available. Panellists were asked to score their treatment preference for either surgery or
angioplasty on an eight-point scale. Outliers (top 10% and bottom 10% responses) were removed. If the remaining 80% of
responses fell within a 3-point range, this was defined as `` agreement''. If they did not, this was considered `` disagreement''.
Results: there was substantial disagreement in 484 (81%) of scenarios in round 1 and 401 (67%) in round 2. This
disagreement was greater among surgeon than radiologists in both round 1 (83 vs 65%) and round 2 (69 vs 42%). Surgeons
also demonstrated less convergence between rounds.
Conclusions: there is substantial disagreement between and among surgeons and radiologists with regard to the
appropriateness of surgery or angioplasty for severe limb ischaemia. This lack of consensus stems from the absence of an
evidence base and means that the same patient may receive entirely different treatment depending on which hospital and
consultant they attend. Not only may this unexplained variation be clinically unsatisfactory, it has major implications for
the planning and use of health service resources.
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In the U.K., over 20 000 patients are treated for severe
limb ischaemia (SLI) each year at an estimated cost of
£1 billion.1 Similar data are available for many other
European countires. The relative indications for
bypass surgery and angioplasty remain controversial
with strongly held and diametrically opposed views
being expressed by surgical and radiological
experts.2±6 Two trials have suggested that surgery
and angioplasty may achieve similar survival and
limb salvage rates in certain patients. However, both
trials were small and methodologically flawed andPlease address all correspondence to: A. Bradbury, Professor of
Vascular Surgery, BASIL Trial Office, Research Institute (Lincoln
House), Heartlands Hospital, Bordesley Green East, Birmingham
B9 5SS, U.K.
On behalf of the BASIL Trial Delphi Consensus Group.
1078±5884/02/05041106 $35.00/0 # 2002 Elsevier Science Ltd. All rprovide little or no evidence on which to base current
treatment.7,8 Clinicians views are, therefore, almost
entirely based upon personal experience, the nature
of their training and the results of uncontrolled obser-
vational studies.
Many vascular surgeons believe that surgery is the
treatment of choice for virtually all patients affected
by SLI. However, angioplasty is increasingly used as a
first-line treatment because surgery is associated with
significant mortality, not all patients have a suitable
vein for bypass and there is a lack of health care
resources and trained personnel to perform these
demanding operations.9 There are also a number of
theoretical advantages to angioplasty; it may be safer,
quicker, less expensive and may not prejudice subse-
quent surgical bypass if required.10 On the other hand
the surgical bypass may provide a more complete
and durable revascularisation of the limb. The Bypassights reserved.
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Fig. 1. Example of an angiographic representation used in
questionnaire.
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(BASIL) trial is an on-going U.K.-based, Health Tech-
nology Assessment funded, multi-centre, randomised,
controlled trial comparing the clinical and cost-
effectiveness of a `` bypass first'' with an `` angioplasty
first'' strategy in patients with SLI.11 To examine the
level of agreement among vascular surgeons and
interventional radiologists with regard to the surgical
and endovascular management of SLI, and to estab-
lish a `` grey area of clinical equipoise'' prior to the start
of the BASIL trial, a Delphi consensus study was
undertaken.
Participants and Methods
Modified Delphi technique
The modified Delphi consensus method is an accepted
means of quantifying the level of agreement among a
group of medical `` experts''.12,13 The technique has
been applied to a wide range of clinical areas includ-
ing interventions for vascular disease.14,15 Briefly, a
panel of `` experts'' is asked to rate independently the
appropriateness of each intervention for a range of
hypothetical clinical scenarios. The median and
range of these first round responses are fed back to
panellists so that that each can see where their
response lay in relation to those of their peers. Panel-
lists are given the opportunity to amend their
response in a second round by completing the ques-
tionnaire again. From these data the initial and final
level of agreement, as well as the degree of conver-
gence between the first and second rounds, can be
quantified.
Panellists
At its inception, the BASIL trial was based in Scotland
and the north-east of England. All the consultant vas-
cular surgeons and interventional radiologists work-
ing in this geographical area had agreed to participate
in the trial. The trial subsequently incorporated
several other English centres. The Delphi consensus
questionnaire was, therefore, sent to all 37 consultant
vascular surgeons and 31 consultant interventional
radiologists working in these areas/centres. Twenty
(54%) surgeons and 17 (55%) radiologists (Appendix 1)
provided complete and evaluable responses for both
rounds.
Delphi questionnaire
Surgeons and radiologists were presented with
596 different hypothetical patient scenarios. ScenariosEur J Vasc Endovasc Surg Vol 24, November 2002provided information regarding the anatomical extent
of disease, whether the patients had rest pain only or
had tissue loss (defined as ulceration and/or gangrene
with or without rest pain) and whether or not a suit-
able vein for bypass was available.
Anatomical extent of disease
Panellists were presented with angiographic represen-
tations (Fig. 1) depicting three main infra-inguinal
segments (superficial femoral artery, popliteal artery
and crural arteries). Each segment was presented as
having either `` no disease'', `` focal (510 cm) non-
occlusive disease'', `` diffuse (410 cm) non-occlusive
disease'', `` short (510 cm) occlusion'' or `` long
(410 cm) occlusion''. In disease scenarios that
included a long occlusion of the crural arteries, parti-
cipants were also asked to consider their response in
the presence of a patent (with `` run-off'') and occluded
(`` without run-off'') pedal arch. Allowing for all pos-
sible disease combinations, this resulted in a total of
149 angiographic representations. We did initially
intend to conduct the study with actual angiogram
Bypass or Angioplasty for Severe Limb Ischaemia 413films. However, it became almost immediately appar-
ent that it was going to be impossible to obtain angio-
grams of sufficient and, importantly, uniform quality
that represented all the (very many ) different combi-
nations of disease. Furthermore, the copying and
transportation of these films to all the panellists
proved to been logistically and financially impossible.
Clinical severity of disease and suitable bypass
Participants were asked to consider each angiographic
representation in the presence of rest pain only versus
tissue loss (ulcer and/or gangrene). Panellists were
asked to assume that all the patients symptom/signs
were due to arterial disease. It was the view of the
Consensus group that the addition of ankle pressure
would not be helpful.
Presence of vein
Participants were asked to consider each angiographic
representation in the presence a suitable vein for
bypass vs no suitable vein. As practice varies with
regard to the relative use of veins other than the ipsi-
lateral long sapheneous vein and prosthetic grafts, the
nature of the conduit to be used was not further pre-
scribed.
Scoring
For each of the 596 scenarios, respondents were asked
to score their preferred treatment option as follows:
(1) Could only be treated by PTA;
(2) Could be treated by PTA or surgery but I strongly
prefer PTA;
(3) Could be treated by PTA or surgery but I prefer
PTA;
(4) Could be treated by PTA or surgery and I have no
preference;
(5) Could be treated by PTA or surgery but I prefer
surgery;
(6) Could be treated by PTA or surgery but I strongly
prefer surgery;
(7) Could only be treated by surgery;
(8) Not amenable to revascularisation ± primary
amputation.
Assumptions
In formulating their responses, participants were
asked to make four assumptions:
(1) There was no significant supra-inguinal or pro-
funda femoris artery disease;
(2) Medical therapy had failed such that revasculari-
sation, either by surgery or PTA, or primary
amputation were the only options;(3) Apart from the information provided to them,
there were no other contra-indications to either
surgery or PTA;
(4) The crural artery depicted was the least diseased
of the three and thus likely to be the target artery
for surgical or endovascular treatment.
Most of the panellists found that it took 1±2 h to
complete each questionnaire.
Data analysis
To allow for direct comparison between rounds only
responses received from the 20 surgeons and 17 radi-
ologists who completed both rounds were considered.
By convention, the highest 10% and lowest 10% of the
responses were discarded as `` outliers''. The remain-
ing responses were deemed to show `` agreement'' if
they fell within a three-point range and `` disagree-
ment'' if they did not. This resulted in 6 possible
agreement groups as follows:
All responses fell Agreement that
with the range
1±3 Angioplasty strongly preferred
2±4 Angioplasty preferred
3±5 No preference
4±6 Surgery preferred
5±7 Surgery strongly preferred
6±8 Surgery/Amputation preferred
The results were analysed for all respondents and for
surgeons and radiologists only. Agreement was also
assessed by means of the weighted Kappa (k) statistic,
which was calculated from a summary table of fre-
quencies based upon the comparison of each possible
pair of raters. As the numbers of observers and sce-
narios are large, these estimates are extremely precise,
and confidence intervals are not presented. A k of less
than 0.40 is defined as poor agreement. Equipoise was
defined as existing when there was a consensus that
both angioplasty and surgery would be equally
clinically effective (3-point agreement for 3±5 `` no pref-
erence'') or where there was disagreement about the
preferred treatment.
Results
Treatment preferences in round 1
In round one, there was little difference between the
distribution of surgical and radiological responses,
both of which were bimodal (Fig. 2). Both surgeons
and radiologists thought primary amputation was
indicated in approximately 9±10% of scenarios.Eur J Vasc Endovasc Surg Vol 24, November 2002
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Fig. 2. Percentage of surgical and radiological responses in each
category in round 1.
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Fig. 3. Percentage of surgical and radiological responses in each
category in round 2.
414 A. W. Bradbury et al.Although both groups felt that surgery was preferred
in the majority of scenarios (surgeons 46% and radi-
ologists 48%), the strength of the preference for sur-
gery was greater for the surgical group. By contrast,
surgeons thought angioplasty was to be preferred in
38%, compared with 35% for radiologists, with the
strength of the preference being very similar between
the two groups. Surgeons and radiologists expressed
no preference for either treatment in 7.5%. It appears
therefore that, in the great majority of scenarios, both
surgeons and radiologists had moderate to strong
preference for one or other treatment. However, with
regard to the level of agreement as to which was the
preferred treatment, when surgical and radiological
responses were combined, the weighted k statistic
was 0.25. Although the weighted k was higher for
radiologists (k 0.29) than for surgeons (k 0.21), all
three k values denote poor agreement.
Treatment preferences in round 2
Although individual respondents frequently changed
their responses in round 2, overall there was little
change in the distribution of surgical or radiological
responses (Fig. 3). Surgeons still felt that most
scenarios warranted surgery but the strength of that
preference diminished and there was some movementEur J Vasc Endovasc Surg Vol 24, November 2002towards angioplasty by both groups. The proportion
of scenarios thought to warrant primary amputation
increased a little as did the proportion in which sur-
geons and radiologists expressed no preference for
either treatment. When surgical and radiological
responses were combined, the weighted k statistic
was 0.38, which was higher than in round one but
still denotes poor agreement. The weighted k for radi-
ologists rose to 0.45, denoting moderate agreement,
but agreement among surgeons remained poor
(k 0.32).
Level of agreement and convergence between rounds
When the surgical and radiological responses were
combined there was substantial disagreement in 484
(81%) of scenarios in round one and 401 (67%) in
round two (Fig. 4). This disagreement was greater
among surgeons than radiologists in both round 1
(83 vs 65%) and round 2 (69 vs 42%) (Table 1).
Although, because of their smaller number, one
would expect a greater level of agreement among
radiologists, this would not account for the large dif-
ferences in the level of consensus observed between
surgeons and radiologists. There was a better level of
agreement among surgeons (k 0.77) than radiolo-
gists (k 0.61) between the first and second rounds.
This was because, in round 2, radiologists were more
likely than surgeons to change their score towards the
group mean on the basis of feedback from round 1.
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Fig. 4. Level of agreement and disagreement regarding the
appropriateness of angioplasty or surgical bypass.
Table 2. `` Grey area of clinical equipoise'' for the BASIL trial.
Agreement within
`` 345'' range (%)
Disagreement
(%)
Total (%)
Round 1
Surgeons 0.0 83 83
Radiologists 4 65 69
Combined 0.0 81 81
Round 2
Surgeons 0.2 69 69
Radiologists 12 42 55
Combined 0.8 67 68
Table 1. Number and percentage of disease scenarios falling into each three-point agreement and disagreement range
for rounds 1 and 2 for surgeons only and radiologists only.
Surgeons only Radiologists only
Round 1 Round 2 Round 1 Round 2
n % n % n % n %
123 25 4 62 10 45 8 93 16
234 32 5 96 16 74 12 136 23
345 0 0 1 0 22 4 72 12
456 0 0 5 1 32 5 61 10
567 46 8 68 11 77 13 86 14
678 21 4 36 6 21 3 50 8
Any agreement 103 17 187 31 210 35 343 58
Disagreement 493 83 409 67 386 65 253 42
Note that some response combinations would appear in the `` any agreement'' line more than once. For example, if there
is a 2-point agreement of `` 23'' this will appear in the `` 123'' and `` 234'' agreement categories.
Bypass or Angioplasty for Severe Limb Ischaemia 415`` Grey area of clinical equipoise'' for the BASIL trial
Equipoise was defined as existing when there was a
consensus that both angioplasty and surgery would
be equally clinically effective (3-point agreement for
3±5 `` no preference'') or where there was disagreement
about the preferred treatment. In round one, 81% of
scenarios fell into the grey area compared with 68% of
scenarios in round 2 (Table 2). In both rounds, the grey
area comprised largely of scenarios in which there
was disagreement rather than scenarios in which
there was agreement that either treatment would be
equally effective.Discussion
The clinically important finding of the study is the
very substantial level of disagreement between and
among surgeons and radiologists with regard to the
appropriateness of surgery or angioplasty for SLI over
a wide range of clinical and angiographic severities of
disease. Despite the fact that the information provided
to the panellists was less complex than would be the
case in the real clinical situation, in round 1 there was
disagreement among surgeons in 83%, and among
radiologists in 65%, of scenarios. Although there was
some convergence of views in round 2 following feed-
back from peers, the level of disagreement was still
69% for surgeons and 42% for radiologists. This lack of
consensus, which is reflected in the literature, stems
from the absence of an evidence base and means that
the same patient may receive entirely different treat-
ment depending on which hospital and consultant
they attend. Indeed, such is the lack of consensus,
that surgeons and radiologists working in the same
institution might disagree fundamentally about which
treatment option is most desirable, possible, or evenEur J Vasc Endovasc Surg Vol 24, November 2002
416 A. W. Bradbury et al.ethical. While some would argue that a good result
can be obtained in exactly the same patient using two
completely different techniques, equivalence in terms
of clinical and cost-effectivness is, in reality, unlikely
and cannot be assumed in the absence of evidence. So
it is our view that the very considerable and largely
unexplained variation in practice demonstrated in this
study is likely to disadvantage patients. Furthermore,
it has major implications for the planning and use of
health service resources, referral pathways and, of
course, surgical and interventional training. Although
the present study has clearly demonstrated a large
collective `` grey area of clinical equipoise'', there is
much less equipoise on the part of individual clini-
cians. The bimodal response distribution observed for
surgeons and radiologists, and which changed rela-
tively little between the two rounds (especially for
surgeons), indicates that most clinicians have strong
preferences as to how individual patients should be
treated; despite a complete absence of level I evidence.
Hopefully, recognition that current practice is not evi-
dence-based, together with the results of this present
study, will encourage the randomisation of patients
into the BASIL trial within the U.K. However, the
difficulty of changing individual clinical opinion can-
not be under-estimated: `` sometimes wrong, but never
in doubt''.
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